Polyrizon Ltd.

PLRZ

$12.25

+1.91%+$0.23

High—

Low—

52W High-32.7%

Rel. vol—

Interval

Range35m

Volume—SMA5SMA10

—

AI analysis

Polyrizon Ltd. is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$12.09

5-period simple moving average

SMA10

$12.19

10-period simple moving average

SMA20

$12.29

20-period simple moving average

SMA50

—

50-period simple moving average

EMA5

$12.13

5-period exponential moving average

EMA10

$12.17

10-period exponential moving average

EMA20

$12.24

20-period exponential moving average

DEMA20

$12.15

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$12.05

Volume weighted average price

MACD

-0.077

Signal -0.053

RSI(14)

53.9

Relative strength oscillator

OBV

-11.29K

On-balance volume

StochRSI

53.9 / 53.9

Fast oscillator pair

BBands Low

$11.84

Lower band

BBands Mid

$12.29

Middle band

BBands High

$12.75

Upper band

Market Cap

14.07M

Company size

P/E Ratio

0.00

Valuation multiple

EV / EBITDA

—

Enterprise value multiple

ROE

-25.4%

Return on equity

ROA

-28.9%

Return on assets

Operating Margin

0.0%

Operating efficiency

Net Margin

0.0%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

-1.34

Market sensitivity

52W High

$18.20

52-week peak

52W Low

$2.88

52-week trough

Supply Chain of PLRZ

Upstream / Downstream / Proxies

Upstream

Eurofins CDMO AmatsiAquitaine S.A.S.EURONEXT:ERFGlobal Preclinical CRO (Undisclosed)UnconfirmedClearmind Medicine Inc.NASDAQ:CMNDUniversity of Parma (Department of Food and Drug)Branding Firm (Undisclosed)Specialty Chemical Suppliers (Sulfated Polysaccharides, Hydrophilic Polymers, Divalent Ion Crosslinkers)

Downstream

Clearmind Medicine Inc.NASDAQ:CMNDClinical Trial Sites (3 U.S. Sites — Texas lead site + 2 additional)Aegis Capital Corp.

Proxies

OptiNose Inc.NASDAQ:OPTN AptarGroup Inc.NYSE:ATRBioDelivery Sciences International (acquired by Collegium)UnconfirmedRedHill Biopharma Ltd.NASDAQ:RDHL

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer